These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26196085)

  • 1. Identification of prostate cancer biomarkers in urinary exosomes.
    Øverbye A; Skotland T; Koehler CJ; Thiede B; Seierstad T; Berge V; Sandvig K; Llorente A
    Oncotarget; 2015 Oct; 6(30):30357-76. PubMed ID: 26196085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers.
    Skotland T; Ekroos K; Kauhanen D; Simolin H; Seierstad T; Berge V; Sandvig K; Llorente A
    Eur J Cancer; 2017 Jan; 70():122-132. PubMed ID: 27914242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation.
    Wang L; Skotland T; Berge V; Sandvig K; Llorente A
    Eur J Pharm Sci; 2017 Feb; 98():80-85. PubMed ID: 27664330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
    Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
    Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers of prostate cancer.
    Fujita K; Nonomura N
    Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
    Rodríguez M; Bajo-Santos C; Hessvik NP; Lorenz S; Fromm B; Berge V; Sandvig K; Linē A; Llorente A
    Mol Cancer; 2017 Oct; 16(1):156. PubMed ID: 28982366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes as biomarker treasure chests for prostate cancer.
    Duijvesz D; Luider T; Bangma CH; Jenster G
    Eur Urol; 2011 May; 59(5):823-31. PubMed ID: 21196075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.
    Nilsson J; Skog J; Nordstrand A; Baranov V; Mincheva-Nilsson L; Breakefield XO; Widmark A
    Br J Cancer; 2009 May; 100(10):1603-7. PubMed ID: 19401683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can urinary exosomes act as treatment response markers in prostate cancer?
    Mitchell PJ; Welton J; Staffurth J; Court J; Mason MD; Tabi Z; Clayton A
    J Transl Med; 2009 Jan; 7():4. PubMed ID: 19138409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer biomarker profiles in urinary sediments and exosomes.
    Dijkstra S; Birker IL; Smit FP; Leyten GH; de Reijke TM; van Oort IM; Mulders PF; Jannink SA; Schalken JA
    J Urol; 2014 Apr; 191(4):1132-8. PubMed ID: 24211598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.
    Adeola HA; Calder B; Soares NC; Kaestner L; Blackburn JM; Zerbini LF
    Future Oncol; 2016 Jan; 12(1):43-57. PubMed ID: 26615920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
    Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
    Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
    Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
    Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
    J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteome.
    Erozenci LA; Böttger F; Bijnsdorp IV; Jimenez CR
    FEBS Lett; 2019 Jul; 593(13):1580-1597. PubMed ID: 31198995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
    Fujita K; Kume H; Matsuzaki K; Kawashima A; Ujike T; Nagahara A; Uemura M; Miyagawa Y; Tomonaga T; Nonomura N
    Sci Rep; 2017 Feb; 7():42961. PubMed ID: 28211531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.